TGM2 and cranioectodermal dysplasia: For the diagnosis of CeD, duodenal biopsy plus positive serological tests (anti-tTG antibodies, anti-endomysium antibodies (EmA), and deamidated gliadin peptide (DGP) antibodies) are the gold standard (248, 249).